Browsing by Author Konitsiotis, S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 70  next >
TitleAuthor(s)Issue date
Acute reversible dyskinesia induced by mirtazapineKonitsiotis, S.; Pappa, S.; Mantas, C.; Mavreas, V.24-Nov-2015
Acute spontaneous spinal subdural haematomas in a patient with essential thrombocythaemiaKonitsiotis, S.; Glantzouni, A.; Argyropoulou, M. I.; Tsapoga, T.; Elisaf, M. S.; Efremidis, S. C.24-Nov-2015
Akathisia induced by mirtazapine after 20 years of continuous treatmentMarkoula, S.; Konitsiotis, S.; Chatzistefanidis, D.; Lagos, G.; Kyritsis, A. P.24-Nov-2015
Akinetic mutism followed by a manic reaction on introduction of steroid replacement for Addison's diseaseKalambokis, G.; Konitsiotis, S.; Pappas, D.; Tsianos, E. V.24-Nov-2015
Amantadine for levodopa-induced dyskinesiasMetman, L. V.; Del Dotto, P.; LePoole, K.; Konitsiotis, S.; Fang, J.; Chase, T. N.24-Nov-2015
Amantadine for levodopa-induced dyskinesias: a 1-year follow-up studyMetman, L. V.; Del Dotto, P.; LePoole, K.; Konitsiotis, S.; Fang, J.; Chase, T. N.24-Nov-2015
Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeysBlanchet, P. J.; Konitsiotis, S.; Chase, T. N.24-Nov-2015
AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeysKonitsiotis, S.; Blanchet, P. J.; Verhagen, L.; Lamers, E.; Chase, T. N.24-Nov-2015
Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanismsChase, T. N.; Oh, J. D.; Konitsiotis, S.24-Nov-2015
Assessment of Tremor Activity in the Parkinson's Disease Using a Set of Wearable SensorsRigas, G.; Tzallas, A.; Tsipouras, M.; Bougia, P.; Tripoliti, E.; Baga, D.; Fotiadis, D.; Tsouli, S.; Konitsiotis, S.24-Nov-2015
Assessment of Tremor Activity in the Parkinson's Disease Using a Set of Wearable SensorsRigas, G.; Tzallas, A. T.; Tsipouras, M. G.; Bougia, P.; Tripoliti, E. E.; Baga, D.; Fotiadis, D. I.; Tsouli, S. G.; Konitsiotis, S.24-Nov-2015
Astrocytoma-like multiple sclerosisPakos, E. E.; Tsekeris, P. G.; Chatzidimou, K.; Goussia, A. C.; Markoula, S.; Argyropoulou, M. I.; Pitouli, E. G.; Konitsiotis, S.24-Nov-2015
Automated Levodopa-induced dyskinesia assessmentTsipouras, M. G.; Tzallas, A. T.; Rigas, G.; Bougia, P.; Fotiadis, D. I.; Konitsiotis, S.24-Nov-2015
Beneficial effect of levetiracetam on levodopa-induced dyskinesias in Parkinson's disease: A double-blind, placebo-controlled, crossover study (the VALID-PD study). Preliminary resultsStathis, P.; Konitsiotis, S.; Tagaris, G.; Hadjigeorgiou, G.; Kiriakakis, V.; Valid-Pd Study Grp24-Nov-2015
Bone mineral density in patients with neurodegenerative versus non-degenerative parkinsonism as diagnosed by (123)I-ioflupane brain scintigraphyArka, A.; Exarchopoulos, T.; Georgiou, A.; Tsiouris, S.; Konitsiotis, S.; Sioka, C.; Papadopoulos, A.; Calef-Ezra, J.; Al-Boucharali, J.; Bougias, C.; Kyritsis, A.; Fotopoulos, A.24-Nov-2015
A case of abetalipoproteinemia with a choreic-ataxic syndrome and none of the known mutationsKonitsiotis, S.; Mokou, C.; Kalantaridou, S.; Syrrou, M.; Kravariti, M.; Tsatoulis, A.24-Nov-2015
The characteristics of Parkinson's disease patients in Greece. A cross sectional hospital-based outpatient studyMentenopoulos, G.; Bostantzopoulou, S.; Katsarou, Z.; Tagaris, G.; Stathis, P.; Konitsiotis, S.24-Nov-2015
Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavengerBlanchet, P. J.; Konitsiotis, S.; Hyland, K.; Arnold, L. A.; Pettigrew, K. D.; Chase, T. N.24-Nov-2015
CNS involvement in primary Sjogren Syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometryTzarouchi, L. C.; Tsifetaki, N.; Konitsiotis, S.; Zikou, A.; Astrakas, L.; Drosos, A.; Argyropoulou, M. I.24-Nov-2015
CNS siderosis after brachial plexus avulsionKonitsiotis, S.; Argyropoulou, M. I.; Kosta, P.; Giannopoulou, M.; Efremidis, S. C.; Kyritsis, A. P.24-Nov-2015